Patient Medication Information: uses, side effects, how to take - Ultiva
ABOUT THIS MEDICATION
What the medication is used for:
ULTIVA® is a pain medication used before and/ or during surgery.
What it does:
ULTIVA® reduces the pain during surgery.
When it should not be used:
ULTIVA® should not be used in patients who:
- are allergic to remifentanil
are pregnant or nursing
What the medicinal ingredient is:
Remifentanil hydrochloride
What the nonmedicinal ingredients are:
Glycine, hydrochloric acid, water for injection.
WARNINGS AND PRECAUTIONS
BEFORE you undergo surgery, tell your doctor or pharmacist if:
- you are pregnant or nursing
- you are allergic to remifentanil
INTERACTIONS WITH THIS MEDICATION
Before taking ULTIVA®, tell your doctor about any other medications that you are using, including:
certain antidepressants (selective serotonin reuptake
inhibitors (SSRI) and serotonin/norepinephrine reuptake inhibitors (SNRI))
- benzodiazepines (Valium, Versed)
- opioids (Morphine, Codeine)
They may interact with ULTIVA®.
PROPER USE OF THIS MEDICATION
Usual dose:
The proper dose is determined by a doctor trained in the administration of analgesics and general anesthesia.
SIDE EFFECTS AND WHAT TO DO ABOUT THEM
Common side effects include: respiratory depression, slow heartbeat, low blood pressure, and skeletal muscle rigidity. Your anesthetist knows how to manage them during surgery.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
You should immediately contact your physician or anesthesia professional if you have any of the following reactions after surgery.
Nausea
Low blood pressure
Vomiting
Muscle tightness
Slow heartbeat
Shivering
Fever
Dizziness
Visual disturbance
Headache
Respiratory depression
Transient cessation of respiration
Itch
Rapid heartbeat
Postoperative pain
High blood pressure
Agitation
Hypoxia
This is not a complete list of side effects. For any unexpected effects while taking ULTIVA®, contact your doctor or pharmacist.
IMPORTANT: PLEASE READ
ULTIVA® Product Monograph Page 30 of 30 REPORTING SUSPECTED SIDE EFFECTS
To monitor drug safety, Health Canada through the Canada Vigilance Program collects information on serious and unexpected effects of drugs. If you suspect you have had a serious or unexpected reaction to this drug you may notify Canada Vigilance:
By toll-free telephone: 866-234-2345
By toll-free fax 866-678-6789
Online: www.healthcanada.gc.ca/medeffect
By email: CanadaVigilance@hc-sc.gc.ca
By regular mail:
Canada Vigilance National Office
Marketed Health Products Safety and Effectiveness Information Division
Marketed Health Products Directorate
Health Products and Food Branch
Health Canada
Tunney’s Pasture, AL 0701C
Ottawa ON K1A 0K9
NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program does not provide medical advice
MORE INFORMATION
This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, AbbVie Corporation at 1-800-699-9948.
